SCHEMBL17876298

SCHEMBL17876298

c1ccc(N2Cc3ccc(-c4cc(-c5cccnc5)cc(-c5cccnc5)c4)cc3-c3cc(-c4ccc5c(c4)oc4ccccc45)ccc3C2)cc1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 5/20 0.38
CYP11B2 P19099 5/20 0.38
CYP19A1 P11511 3/20 0.37
TDP2 O95551 2/20 0.37
ALDH1A1 P00352 3/20 0.37
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
HPGD P15428 1/20 0.37
RAB9A P51151 1/20 0.37
HSD17B10 Q99714 1/20 0.37
PIM1 P11309 2/20 0.36
PIM2 Q9P1W9 2/20 0.36
PIM3 Q86V86 1/20 0.36
PGR P06401 1/20 0.35
GBA1 P04062 2/20 0.35
GAA P10253 1/20 0.35
CYP1A2 P05177 1/20 0.35
HTT P42858 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17876266 0.96 CYP11B1 (0.37) CYP11B1CYP11B2CYP19A1TDP2ALDH1A1
SCHEMBL17876240 0.96 CYP11B1 (0.37) CYP11B1CYP11B2CYP19A1TDP2ALDH1A1
SCHEMBL17876304 0.94 PIM1 (0.38) CYP11B1CYP11B2CYP19A1TDP2ALDH1A1
SCHEMBL17876268 0.90 CYP11B1 (0.37) CYP11B1CYP11B2CYP19A1TDP2ALDH1A1
SCHEMBL17876245 0.90 CYP11B1 (0.37) CYP11B1CYP11B2CYP19A1TDP2ALDH1A1
SCHEMBL17876297 0.89 PRKDC (0.41) ALDH1A1MAPTKDM4ENPC1HPGD
SCHEMBL17876311 0.89 ALK (0.36) CYP11B1CYP11B2CYP19A1TDP2ALDH1A1
SCHEMBL17876295 0.88 ALOX5 (0.42) CYP11B1CYP11B2TDP2PIM1PIM2
SCHEMBL17876293 0.87 NPC1 (0.41) ALDH1A1MAPTKDM4ENPC1HPGD
SCHEMBL17876310 0.87 CYP11B2 (0.48) CYP11B1CYP11B2CYP19A1TDP2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-03-03 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2016-06-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10581000-B2 Condensed cyclic compound and organic light-emitting device including the same CRY1, CRY2, CCNE2 CYP11B1 938/4885CYP11B2 1374/4885CYP19A1 167/4885
US-20160190482-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNE2 CYP11B1 938/4885CYP11B2 1374/4885CYP19A1 167/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.